{
  "id": 3039473,
  "title": "Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases",
  "url": "https://urgent.news/2026/08/24/seek-labs-and-namru-eurafcent-enter-crada-to-evaluate-field",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T14:30:59.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/seek-labs-and-namru-eurafcent-enter-crada-to-evaluate-field-deployable-diagnostics-for-infectious-diseases"
  },
  "original_language": "en",
  "account": null,
  "summary": "SALT LAKE CITY, Aug. 24, 2026 (GLOBE NEWSWIRE) — Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Unit (NAMRU) EURAFCENT, part of Navy Medicine Research & Development that is focused on infectious disease threats […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}